Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats. by Homberg, J.R. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/69545
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Psychopharmacology (2008) 200:367-380 
DOI 10.1007/s00213-008-1212-x OpenAccess
ORIGINAL INVESTIGATION
Adaptations in pre- and postsynaptic 5-HT1A
receptor function and cocaine supersensitivity in serotonin
transporter knockout rats
Judith R. Homberg • Sietse F. De Boer •
Halfdan S. Raas0 • Jocelien D. A. Olivier •
Mark Verheul • Eric Ronken • Alexander R. Cools • 
Bart A. Ellenbroek • Anton N. M. Schoffelmeer • 
Louk J. M. J. Vanderschuren • Taco J. De Vries • 
Edwin Cuppen
Received: 21 January 2008 /Accepted: 25 May 2008/Published online: 27 June 2008 
© The Author(s) 2008
Abstract
Rationale While individual differences in vulnerability to 
psychostimulants have been largely attributed to dopami­
nergic neurotransmission, the role of serotonin is not fully 
understood.
Objectives To study the rewarding and motivational prop­
erties of cocaine in the serotonin transporter knockout 
(SERT-/-) rat and the involvement of compensatory 
changes in 5-HT1A receptor function are the objectives of 
the study.
Materials and methods The SERT / rat was tested for 
cocaine-induced locomotor activity, cocaine-induced con­
ditioned place preference, and intravenous cocaine self­
administration. In addition, the function and expression of 
5-HT1A receptors was assessed using telemetry and
autoradiography, respectively, and the effect of 5-HT1A 
receptor ligands on cocaine’s psychomotor effects were 
studied.
Results Cocaine-induced hyperactivity and conditioned 
place preference, as well as intravenous cocaine self­
administration were enhanced in SERT- -  rats. Furthermore, 
SERT-/- rats displayed a reduced hypothermic response to 
the 5-HT1A receptor agonist 8-OHDPAT. S-15535, a 
selective somatodendritic 5-HT1A receptor agonist, reduced 
stress-induced hyperthermia (SIH) in wild-type controls 
(SERT+ +), while it increased SIH in SERT / rats. As 5- 
HT1A receptor binding was reduced in selective brain 
regions, these thermal responses may be indicative for 
desensitized 5-HT1A receptors. We further found that both 
8-OHDPAT and S-15535 pretreatment increased low-dose
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cocaine-induced locomotor activity in SERT- -  rats, but not 
SERT+/+ rats. At a high cocaine dose, only SERT+/+ 
animals responded to 8-OHDPAT and S-15535.
Conclusion These data indicate that SERT / -associated 5- 
HT1A receptor adaptations facilitate low-dose cocaine 
effects and attenuate high-dose cocaine effects in cocaine 
supersensitive animals. The role of postsynaptic and 
somatodendritic 5-HT1A receptors is discussed.
Keywords Knockout rat. Serotonin transporter. Cocaine 
self-administration. 5-HT1A receptor. Postsynaptic . 
Somatodendritic
Abbreviations
CPP conditioned place preference
DA dopamine
DAT dopamine transporter
ENU N-ethyl-nitrosurea
FR fixed ratio
NA noradrenaline
NET noradrenaline transporter
PR progressive ratio
SERT serotonin transporter
SERT- - homozygous serotonin transporter knockout
rat
SERT+- heterozygous serotonin transporter knockout
rat
SERT+/+ wild-type control rat
SIH stress-induced hyperthermia
SSRI selective serotonin reuptake inhibitor
5-HT serotonin
5-HTTLPR serotonin transporter-linked polymorphic region
Introduction
Drug addiction is an important health problem and a major 
socioeconomic issue that affects millions of people in the 
Western society (Uhl and Grow 2004). As the impact of 
cocaine addiction on health and economy escalates, so too 
does the need to understand its pathogenesis. Cocaine 
exerts its behavioral effects primarily via inhibition of the 
dopamine transporter (DAT), noradrenaline transporter 
(NET), and the serotonin transporter (SERT; Heikkila et 
al. 1975), with approximately equal affinity for each 
transporter (Reith et al. 1980). While dopamine (DA) has 
been the primary focus in research on individual differences 
in the effects of cocaine (Deminiere et al. 1989), accumu­
lating evidence suggest that serotonin (5-hydroxytrypta- 
mine, 5-HT) plays an important modulatory role in cocaine 
reward, although this process is not fully understood. For 
example, chronic treatment with the selective serotonin
reuptake inhibitor (SSRI) fluoxetine in preclinical and 
clinical trials resulted in both positive and negative effects 
on cocaine self-administration and cocaine’s subjective 
effects (Walsh and Cunningham 1997).
The Na /Cl -dependent SERT regulates the re-uptake of 
extracellular 5-HT (Murphy et al. 1998) and thereby is the 
most critical regulator of extracellular 5-HT levels. Hence, 
SERT blockade by cocaine results into constitutive increased 
extracellular 5-HT levels, and secondary, activation of various 
5-HT receptors that directly, or indirectly via the dopaminergic 
or noradrenergic systems, may influence the rewarding and 
motivational properties of cocaine (Acosta et al. 2005; 
Burmeister et al. 2004). Individual differences in central 5- 
HT levels have been proposed to influence personality in a 
trait-like manner (Serretti et al. 2006), suggesting that such 
individual differences are constitutive (Highley and Linnoila
1997) and genetically determined. The well-known poly­
morphism in the human SERT gene (5-HTTLPR; Heils et al. 
1996) might underlie these individual differences, but the 
linkage between this polymorphism and cocaine addiction 
has been rarely explored, and findings are inconsistent 
(Mannelli et al. 2006; Gerra et al. 2007). To address how 
constitutive changes in central serotonergic activity and 
associated compensatory adaptations affect the behavioral 
effects of cocaine, a SERT knockout model with a disturbed 
serotonergic homeostasis and potential compensatory adap­
tations in the serotonergic system is a useful tool. A SERT 
knockout mouse is available (Bengel et al. 1998) and has 
been shown to exhibit enhanced cocaine-induced condi­
tioned place preference (CPP; Sora et al. 1998, 2001), but 
reduced cocaine-induced hyperactivity (Wichems et al.
1998). Hence, it is not known whether the role of 5-HT is 
limited to cocaine’s rewarding and psychomotor effects, or 
extends to cocaine’s reinforcing and motivational properties 
that sustain intravenous cocaine self-administration behavior. 
The latter is of particular interest because of the high face 
and predictive validity with human drug self-administration 
behaviour (Griffith et al. 1980).
Recently, we identified a rat knockout for the SERT gene 
using an ENU-driven target-selected mutagenesis approach 
(Smits et al. 2006). Because intravenous drug self-admin­
istration has been well established in the rat, and because 
there is a wealth of literature available on drug-related 
pharmacology in this species, we used this unique rat 
knockout strain to address the questions whether the 
constitutive absence of the SERT affects cocaine’s psycho­
motor effects, cocaine-induced conditioned place prefer­
ence, and intravenous cocaine self-administration and 
whether compensatory adaptations are involved in the 
knockout’s response to cocaine. The SERT knockout rat 
completely lacks functional SERT, displays increased 
extracellular 5-HT levels and a reduction in 5-HT turnover 
and recycling, while the presynaptic functioning of non-
Ô  Springer
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serotonergic systems under basal conditions is not affected 
(Homberg et al. 2007). Here, we studied cocaine’s psycho­
motor effects and intravenous cocaine self-administration in 
this model, and we addressed the contribution of compen­
satory adaptations at the 5-HT receptor level.
Material and methods
Animals
All experiments were approved by the Animal Care 
Committee of the Royal Dutch Academy of Science, the 
Free University of Amsterdam, the University Medical 
Center Utrecht, and the University of Groningen.
The SERT knockout (SERT-/-) rat (Slc6a41Hubr) was 
generated by target-selected ENU-induced mutagenesis in a 
Wistar (Wistar/Crl) background (for detailed description, 
see Smits et al. 2006). Experimental animals were gener­
ated from incrosses between heterozygous SERT knockout 
(SERT+ -) rats that have been outcrossed for at least six 
generations, and we always compared SERT  + ++) 
littermates. At the age of 3 weeks, ear cuts were taken 
under anesthesia and used for genotyping (see Smits et al.
2006 for a detailed description; Forward primer: position 
3401, TCACAAAGCACTGAGACCAG; Reverse primer: 
position 4071, AACCTGCCAAGAGAGAGTTG). Ani­
mals were housed under standard conditions in groups of 
two to four per cage under controlled experimental 
conditions (12-h light-dark cycle, 21±1°C, 60% relative 
humidity, food and water ad libitum), except where stated 
otherwise. Only male rats were used.
Quantitative autoradiography
The procedure as described in Homberg et al. (2007) was used 
with minor modifications. The tissue sections were pre­
incubated for 20 min at room temperature in 50 mM Tris- 
HCL buffer at pH 7.4 ([3H]WAY-100635). Subsequently, the 
sections were incubated in fresh buffer containing 3 nM [3H] 
WAY-100635 (40.0 Ci/mmol) for 1 h at room temperature. 
The air-dried sections together with [3H]Microscales™ stand­
ards (GE Healthcare, UK) were apposed to a [ H]hyperfilm 
(GE Healthcare, UK) and developed after 8 weeks. Optical 
densities were converted into fmol/mg of tissue equivalent 
using the standard curve. Nonspecific binding was deter­
mined by adding 10 |oM 8-OHDPAT to the incubation buffer.
Pharmacological challenge test using body temperature 
telemetry
Animals were housed under a fixed 12 h light/dark period 
(lights off at 1 pm). Under isoflurane anesthesia, rats were
surgically equipped with a temperature-sensitive radio-trans­
mitter (TA10TA-F40, Data Sciences, St. Paul, MN, USA) in 
the peritoneal cavity as described previously (Meerlo et al.
1999). After surgery, the rats were individually housed in test 
cages that were placed on receivers (Data Sciences, St. Paul, 
MN, USA) and allowed to recover for at least 1 week before 
drug challenge tests. Body temperature was sampled every 
5 min for 10 sec starting 24 hr before the drug challenges. 
Drug challenge tests were performed at 4 h before lights off. 
Animals received saline [1 ml/kg, s.c.; stress-induced 
hyperthermia (SIH)], S-15535 (2.5 and 5.0 mg/kg, s.c.), 
and 8-OHDPAT (0.25 mg/kg, s.c.) in a randomized fashion 
(at least 2 days separated each challenge test).
Cocaine-induced locomotor activity
Locomotor activity was recorded by video tracking in 
Phenotyper® cages (Noldus Information Technology, 
Wageningen, The Netherlands; de Visser et al. 2005). The 
cages (45 x 45 x 45 cm), made of transparent Perspex walls 
and a black floor, were equipped with an empty feeding 
station. Each cage had a top unit containing a built-in 
digital infrared-sensitive video camera, infrared lighting 
sources, and hardware needed for video tracking (Ethovi- 
sion 3.0, Noldus Information Technology, Wageningen, 
The Netherlands).
Male SERT+ + and SERT- -  rats were allowed to habituate 
to the Phenotyper cages during 30 min 1 day before the test 
(=novelty-induced locomotor activity). On the test day, 
animals underwent the following treatments: 0-30 min = 
habituation; 30-60 min = vehicle (saline or H2O, i.p. or s.c.) 
injection; 60-80 min = pretreatment injection: saline (i.p.), 
2.5 mg/kg S-15535 (s.c.), 0.25 mg/kg 8-OHDPAT (s.c.), or 
0.05 and 0.3 mg/kg WAY-100635 (s.c.); 80-200 min cocaine 
(0, 10, 20 mg/kg, i.p.) injection. All combinations of 
pretreatment and cocaine dose were tested in separate naive 
rats. Using Ethovision 3.0, horizontal locomotor activity was 
analyzed as distance moved (cm), and center activity was 
analyzed as time spent in the center of the cage. Data are 
expressed in 10 min bins.
Cocaine-induced conditioned place preference
Three-compartment Perspex boxes were used (TSE, Bad 
Homburg, Germany), one chamber [30x30x25 cm (lxw xh)] 
had black and white striped walls a wire mesh (small) floor, 
and one chamber [30x30x25 cm (lxw x h)] had black walls 
and a wire mesh (large) floor. The central space (10x30x 
25 cm (lx w x h)) had white walls. In both conditioning 
chambers and in the central space, a dim white house light 
(20-30 lx) was turned on. During the pretest, rats were 
allowed to freely explore all three chambers during 15 min. 
The cocaine-paired chamber was allocated in a counter­
^  Springer
370 Psychopharmacology (2008) 200:367-380
balanced fashion to the animals’ initially preferred and non­
preferred chamber, respectively. During the conditioning 
phase, the rats were confined to a given chamber during 
40 min after i.p. injection of cocaine (5, 7.5 or 10 mg/kg) or 
saline. On alternating days, animals received four cocaine 
pairings and four saline pairings in separate chambers. A 15- 
min test was performed 24 h after the last conditioning 
session, during which the animals were allowed to freely 
explore all compartments in a drug-free state.
Intravenous cocaine self-administration
One week before the start of the experiment, rats were 
equipped with intravenous silicon catheters in the right jugular 
vein under isoflurane anesthesia (De Vries et al. 1998). 
Catheter patency was maintained by daily infusion of 
0.15 ml of a sterile saline solution containing heparin 
(20 U/ml) and weekly checked by short-lasting anesthesia 
induced by thiopenthal infused via the catheter. After 
surgery, rats were individually housed. The standard self­
administration boxes (Med Associates, GA, USA), housed in 
ventilated enclosures, were fitted with two small nose-poke 
holes. A nose poke in the hole designated as “active” 
resulted in the delivery of 50 |o.l of a cocaine solution in 2 s. 
A red house light was turned on during the entire self­
administration session, a red stimulus light above the active 
hole was turned off when an active response was made, and 
remained off during the time-out period (15 s), and a yellow 
stimulus light in the active hole was switched on during the 
cocaine infusion (2 s). Nose pokes in the inactive hole had 
no programmed consequences. Acquisition was performed 
on a fixed ratio 1 (FR1) schedule during daily sessions, and 
cocaine dose (from 0.3 to 0.6 mg/kg/infusion) was increased 
when stable responding was achieved. There was no limit to 
the number of cocaine infusions that could be earned. During 
the subsequent progressive ratio (PR) schedule, the animals 
had to successively increase the number of nose pokes to 
obtain a cocaine injection according to the following 
sequence of required nose pokes: 1, 2, 4, 6, 9, 12, 15, 20, 
25, 32, 40, 50, 62, 77, 95, 118, 145, 178, 219, 268, 328, 402, 
492, 603, etc. PR sessions lasted 4 h or were terminated 
when 1 h elapsed without a drug infusion. Cocaine doses 
(0.3, 0.6 and 0.9 mg/kg/infusion) were gradually increased 
when stable responding was achieved. After the PR schedule 
the animals underwent three FR1 sessions and were 
subsequently subjected to 15 extinction sessions lasting 1 h 
during which active hole nose poking had no programmed 
consequences (no cocaine and no cue light).
Radioligand and drugs
4-(benzodioxan-5-yl) 1-(indan-2-yl)piperazine methanosul- 
fonate (S-15535) was a gift of Servier Pharmaceuticals,
France. (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin hydro­
bromide (8-OHDPAT), WAY-100635, and 5-HT were 
purchased from Sigma-Aldrich (Zwijndrecht, The Nether­
lands). [3H]WAY-100635 and [3H]GR125743 were 
obtained from GE Healthcare (UK), and cocaine was 
purchased from O.P.G. (Utrecht, The Netherlands). S- 
15535, 8-OHDPAT and WAY-100635 were dissolved in 
H2O, and cocaine and CP94,253 were dissolved in saline. 
All drug solutions were freshly prepared 1 h before the 
experiment and administered in a volume of 1 ml/kg.
Statistics
All data were checked for normality and homogeneity. The 
number of active hole pokes during acquisition of cocaine 
self-administration data was analyzed using two-way 
repeated measures ANOVA. During the PR schedule, the 
mean of the last two (out of four) sessions of each cocaine 
dose was used for two-way repeated measures ANOVA 
across all doses. Extinction data were divided into three 
parts of five sessions, and the means over the five sessions 
were subjected to a two-way repeated measures ANOVA. 
Furthermore, a paired  Student’s t test was used to analyze 
the CPP data, which were expressed as the time spent in the 
cocaine-paired chamber during the posttest minus the time 
spent in the cocaine-paired chamber during the pretest. 
Cocaine-induced hyperactivity was analyzed in 10 min bins 
and subjected to two-way ANOVA over 1 h. The 
pretreatment periods before the cocaine challenges were 
analyzed separately. The saline pretreatment group served 
as control and was included in all analyses. Genotype 
served as between factor, and time and treatment were 
combined as within factor. Novelty-induced locomotor 
activity, summed over 30 min, was analyzed using 
Student’s t test. Furthermore, two-way ANOVA was used 
to analyze telemetry data. Finally, autoradiography densities 
were analyzed per brain region and subjected to two-sample 
Student’s t tests. ANOVA’s were followed by Newman- 
Keuls post hoc test when significant (P<0.05) interactions 
were obtained [nonsignificant (n.s.)].
Results
Enhanced rewarding properties of cocaine in SERT-/- rats
We tested the rewarding and motivational properties of 
cocaine in three different procedures that measure distinct 
aspects of cocaine’s behavioral effects. First, we investigat­
ed cocaine reinforcement using the intravenous cocaine 
self-administration procedure. Although there was no 
significant genotype effect over 0.3 and 0.6 mg/kg cocaine 
per infusion during acquisition under an FR1 schedule of
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reinforcement [Fig. 1a; F (2,53)=2.92, n.s.], repeated mea­
sures ANOVA indicated that the genotype x dose interaction 
was significantly different [F(24,53)=3.57, P <0.05]. Accord­
ing to the Newman-Keuls post hoc test, SERT-/- rats self­
administered higher amounts of cocaine when the 0.3 mg/ 
kg cocaine dose was available than SERT+ + and SERT+/ 
rats [P<0.05], but there were no genotype differences at
0.6 mg/kg cocaine per infusion. When the knockout rats 
were subsequently tested under a PR schedule of reinforce­
ment, measuring the motivation to work for a drug injection 
(Hodos 1961; Richardson and Roberts 1996), no genotype 
differences were found [Fig. 1b; F(2,77)=2.41, n.s.], but 
there was a significant genotype x dose interaction [F(4,77)= 
3.41, P <0.05]. Post hoc testing indicated that at 0.9 mg/kg
Fig. 1 a Acquisition of intravenous cocaine self-administration under 
an FR1 schedule in SERT+/+, SERT+/- and SERT-/- rats. Male rats 
(n=8-14) had access to increasing doses of cocaine (0.3, 0.6 mg/kg/ 
infusion) during 1-h sessions. Data represent mean (±SEM) number of 
responses made in the cocaine-paired (active) hole. *P<0.05 different 
from SERT+/+ and SERT+/- rats. b Intravenous self-administration of 
increasing cocaine doses (0.3, 0.6 and 0.9 mg/kg/infusion) under a PR 
schedule during 4-h sessions. Data represent mean (±SEM) number of 
responses made in the cocaine-paired (active) and inactive hole.*P< 
0.05 different from SERT+/+ and SERT+/- rats. c Extinction respond­
ing in SERT+/+, SERT+/- and SERT-/- rats during 1-h sessions. Data
cocaine-paired (active) hole. *P<0.05 different from SERT++ and 
SERT+/- rats. d Cocaine-induced place preference induced by 5, 7.5, 
and 10 mg/kg cocaine in male SERT+/+ and SERT-/- rats. The rats 
(n=6-8) received four cocaine and four saline conditioning trials. 
Time scores represent mean (±SEM) differences between post- and 
preconditioning time spent in the cocaine-paired chamber. *P<0.05 
different from SERT+/+ rats, # P<0.05 posttest different from pretest. 
e Cocaine-induced hyperactivity in male SERT+/+ and SERT-/- rats (n= 
4-7). 0-30 min = habituation, 30-60 min = saline injection (i.p.), 60­
80 min = saline injection (i.p.), 80-200 min = 10 or 20 mg/kg cocaine 
injection (i.p.). Data are expressed as mean (±SEM) cm distance moved
represent mean (±SEM) number of responses made in the previously in 10 min bins. *P<0.05 different from SERT rats
^  Springer
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cocaine per infusion, SERT-/- rats obtained significantly 
more cocaine infusions than SERT+ + and SERT+- rats [P< 
0.05], which required them to emit approximately three times 
more active hole responses (not shown). Inactive responding 
was not different during the FR1 schedule [F(2370)=1.35, n.s.; 
not shown], but there was a significant genotype effect during 
the PR schedule [F(277)=4.95, P <0.05]. During extinction, a 
significant genotype x session interaction was found [Fig. 1c 
F(477)=6.52, P<0.0005], attributed to higher responding in
SERT rats compared to SERT- -  and SERT -  rats during 
the first five extinction sessions [P<0.05] and higher 
responding in SERT- -  rats compared to SERT+ + and 
SERT+/ rats during sessions 6-15 [P<0.05].
Next, SERT+/+ and SERT-/- rats were tested in the CPP 
test that assesses the attribution of incentive salience to 
environmental stimuli associated with the subjective effects 
of drugs (Carr et al. 1989, Tzschentke 1998). Because the 
cocaine self-administration experiment did not reveal a 
heterozygous genotype effect, SERT+- rats were not 
included. We found that 5 mg/kg cocaine [Fig. 1d; T(1,13) 
(genotype) = 1.8667, P<0.05; T(114) (SERT / , pre- vs. 
posttest)=1.912, P<0.05; T(112) (SERT+/+, pre vs. post- 
test)=0.3121, n.s.] and 7.5 mg/kg cocaine [T(1j15) (geno- 
type)=0.538, n.s.; T(116) (SERT-/-, pre vs. post-test)=3.00, 
P <0.005; T(114) (SERT+/+, pre vs. post-test)= 1.444, n.s.] 
induced conditioned place preference in SERT-/- rats, but 
not in SERT+ + rats. A dose of 10 mg/kg cocaine induced 
place preference in both genotypes, but the place preference 
was significantly enhanced in SERT-/- rats compared to 
SERT+/+ rats [T(114) (genotype)=2.229, P<0.05; T(114) 
(SERT-/-, pre- vs. posttest)=3.806, P<0.001; T(114)
leftward, and possibly upward, shift in the dose-effect 
relationship of cocaine demonstrates that SERT-/- rats are 
more sensitive to the rewarding effects of the drug.
Finally, we measured the psychomotor stimulant effects of 
10 and 20 mg/kg cocaine. Overall, SERT rats, compared to 
SERT++ rats, displayed significantly increased cocaine- 
induced locomotor activity [Fig 1e; F(1 120)= 18.95, P < 
0.0001]. No genotype difference were observed after 
10 mg/kg cocaine, and no genotype differences were 
observed in center time upon 10 and 20 mg/kg cocaine [T 
(1,120)=0.25; not shown]. Analysis of the first 30 min after 
placement into the test cage did not reveal genotype differ­
ences [T(117)=0.32], indicating that SERT / and SERT+/+ 
rats do not differ in novelty-induced locomotor activity.
Desensitization of 5-HT1A receptors
We measured the sensitivity of 5-HT1A receptors by 
measuring 8-OHDPAT-induced hypothermia and the effect 
of S-15535 on stress-induced hyperthermia (SIH). Two-way 
ANOVA, including genotype, the effect of saline and of 
0.25 mg/kg 8-OHDPAT over time, revealed a significant 
genotype effect on body temperature [Fig. 2; F(2,1510)= 
29.32, P<0.0001] and a significant genotype x time 
interaction [F(142 1510)=2.89, P<0.0001]. Post hoc testing 
indicated that 8-OHDPAT significantly reduced body
+/- ratstemperature in SERT rats [P<0.05], in SERT 
[P <0.05], and in SERT-/- rats [P <0.05] over all time 
points, except the first 10 min in SERT+ + rats. In addition, 
8-OHDPAT-induced hypothermia was less strongly, in 
SERT / rats compared to SERT+ + and SERT+/ rats [P< 
(SERT+ +, pre- vs. posttest)=2.237, P <0.05]. This apparent 0.05] from 20 to 60 min, and significantly different between
Fig. 2 a 8-OHDPAT-induced (0.25 mg/kg, s.c.) hypothermia and S- 
15535-mediated (2.5 and 5.0 mg/kg, s.c.) inhibition of stress-induced 
(handling and s.c. injection) hyperthermia in male SERT+/+, SERT+/-, and 
SERT-/- rats (n=7). The hypothermic response was registered for 180 min
after saline or 8-OHDPAT administration and for 90 min after S-15535 
administration. Data are expressed as mean (±SEM) change in body 
temperature (°C) per 5 min. For clarity reasons, significant differences are 
not indicated in the figure but are described in the results section
Ô  Springer
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SERT+-  and SERT+ + rats at 25, 35, 40, 50, and 60 min 
after treatment.
Analysis of the effect of 2.5 and 5.0 mg/kg S-15535 on 
SIH revealed a significant genotype effect [Fig. 2; F(2,1119)= 
113.34, P <0.0001] as well as significant genotype x time 
interaction [F(1061119)=3.88, P <0.0001]. Post hoc testing 
indicated that S-15535 reduced SIH in SERT+/+ [P<0.05] 
and SERT+- [P<0.05] rats at 5.0 mg/kg over the entire 
time course [P<0.05] and at 2.5 mg/kg from 0 to 70 min 
after S-15535 administration. In contrast, in SERT- -  rats, 
SIH was significantly increased by 2.5 and 5.0 mg/kg 
S-15535 [P<0.05] from 25 to 60 min after S-15535 
administration. The effect of 2.5 mg/kg S-15535 compared 
to 5 mg/kg S-15535 was not significantly different in all 
three genotypes, except for the last 15 min in SERT+ rats 
and the last 20 min in SERT+ + rats. The response to both 
doses of S-15535 was significantly different between 
SERT- -  rats compared to SERT+- and SERT+ + rats [P< 
0.05] from 20 min to the end of the measurement, except 
for 2.5 mg/kg S-15535 at 80 and 85 min. Furthermore, the 
SIH was significantly decreased in SERT-/- rats compared 
to SERT+ + and SERT+/ rats at 15-30 min after the saline 
injection [P<0.05]. Finally, no genotype differences were 
found between SERT+ + and SERT+/ rats.
[3H]WAY-100635 binding to 5-HT1A receptors was 
reduced in the dorsal raphe nuclei, in the CA2 and CA3 
regions of the hippocampus, and in the cingulate cortex of 
SERT- -  rats. No genotype differences were found in the 
CA1 region of the hippocampus, the septum, and piriform 
cortex (Fig. 3; Table 1).
Fig. 3 Representative [ H]WAY-100635 autoradiograms of coronal 
sections from male SERT+/+ and SERT-/- rats (n=2-3). CX Cingulate 
cortex, CA1, CA2, CA3 hippocampal layers, dRN dorsal raphe 
nucleus, pir CX piriform cortex. See Table 1 for 5-HT1A receptor 
quantification
5-HT1A receptor desensitization interferes with enhanced 
cocaine-induced hyperactivity in SERT- -  rats
To study whether the SERT-/--mediated altered responsiv- 
ity to 5-HT1A receptor agonists contributes to cocaine 
supersensitivity, we tested the effect of 8-OHDPAT and 
S15535 on cocaine’s psychomotor effects induced by a low 
(10 mg/kg) and high (20 mg/kg) dose of the drug. 8- 
OHDPAT, 0.25 mg/kg, pretreatment before 10 or 20 mg/kg 
(Fig. 4a,b) cocaine challenges induced a significant overall 
pretreatment effect [F(134) (pretreatment 8-OHDPAT vs. 
vehicle -1 0  mg/kg cocaine)=13.59, P<0.001; F(150) (pre­
treatment 8-OHDPAT vs. vehicle -2 0  mg/kg cocaine)= 
46.22, P <0.0001]. This indicates that 8-OHDPAT induced 
activity more strongly in SERT+ + rats compared to SERT / 
rats [P<0.05], which was accompanied with signs of the 5- 
HT syndrome (flat body posture and forepaw treading; not 
shown) in SERT+ + rats, but not SERT- -  rats. A subsequent 
10-mg/kg cocaine challenge induced an overall highly 
significant genotype effect (Fig. 4a; F(1 104)=30.79, P < 
0.0001), which was due to an increased locomotor response 
in SERT rats. Upon a 20-mg/kg cocaine challenge, the 8- 
OHDPAT pretreatment did not induce an overall pretreat­
ment effect [Fig. 4b; F(1 143)=2.65, n.s.], but did induce a 
significant genotype x pretreatment interaction [F(11143)= 
4.79, P <0.0001]. Post hoc testing indicated that at 10 [P< 
0.05] and 20 [P<0.05] min after the 20 mg/kg cocaine 
challenge, 8-OHDPAT pretreatment significantly enhanced 
locomotor activity in SERT+ + rats compared to SERT- -  
rats. Furthermore, 8-OHDPAT pretreatment significantly 
enhanced locomotor activity in SERT+ + rats at 10, 20, 40, 
50, and 60 min after the cocaine challenge compared to 
vehicle pretreatment in SERT+ + rats [P<0.05], while the 
locomotor response to 20 mg/kg cocaine was not further 
enhanced in 8-OHDPAT pretreated SERT- -  rats compared 
to vehicle pretreated SERT- -  rats. Analysis of centre time 
revealed that 8-OHDPAT had no significant effect com­
pared to saline pretreatment upon the 10 mg/kg cocaine 
challenge [F(11104) (pretreatment effect)=1.83, n.s.; F(1104) 
(genotype effect)<0.001, n.s.; not shown]. Upon the 20 mg/kg 
cocaine challenge, 8-OHDPAT decreased center time in both 
SERT+/+ and SERT- -  [F(11,143)=6.61, P<0.0001; not 
shown], without genotype differences [F(1143)<0.001, n.s.; 
not shown].
In contrast to 8-OHDPAT, S-15535 (2.5 mg/kg) pretreat­
ment (before cocaine) did not induce an overall pretreat­
ment effect [Fig. 4c F(136) (pretreatment S-15535 vs. 
vehicle -1 0  mg/kg cocaine)=0.59, n.s.; F(156) (pretreatment 
S-15535 vs. vehicle -  20 mg/kg cocaine)=1.20, n.s.]. Upon 
the 10 mg/kg cocaine challenge, there was a highly 
significant overall genotype effect [Fig. 4c; F(1109)= 
26.49, P <0.0001] and genotype x pretreatment interaction 
[F(11j109)=2.32, P<0.05]. Post hoc testing revealed that at
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Table 1 5-HT1A receptor 
quantification in brain areas of 
SERT-/- rats and control 
littermates
Optical densities were converted 
into fmol/mg of tissue equivalent 
using [3 H]Microscales ™ 
standards. The data represent 
mean fmol/mg tissue (±SEM). 
a SERT-/- different from 
SERT+/+
Region [3H]WAY-100635
Bregma SERT+/+ SERT-/- Student’s t test
Septum 0.12 150±12.8 156±11.2 T(1,17) = 0.28
Cingulate cortex 0.12 72±1.8 47±1.7a T(1,25)=9.46, P<0.0001
Piriform cortex -4.68 78±5.6 77±5.3 T(1,20)=0.045
CA1 (hippocampus) -4.68 209±19.3 167±1.8 T(1,13) = 1.74
CA2 (hippocampus) -4.68 239±19.6 190±14.1a T(114)=2.05, P<0.05
CA3 (hippocampus) -4.68 223±15.6 178±0.8a T(1,12)=1.88, P<0.05
Dorsal RN -6.50 107±4.2 89±0.6a T(12)=3.88, P<0.05
10, 20, 30, 40, and 50 min after the 10 mg/kg cocaine 
challenge, S-15535-pretreated SERT / rats displayed in­
creased locomotor activity compared to SERT++ rats [P< 
0.05]. Relative to vehicle pretreatment, S-15535 pretreatment 
potentiated the locomotor response induced by 10 mg/kg 
cocaine in SERT++ rats at 10 and 20 min after the cocaine 
challenge [P<0.05] and at 10, 20, 30, 40 and 50 min after 
the cocaine challenge in SERT- -  rats [P<0.05]. Upon 
20 mg/kg cocaine, there was a significant overall genotype 
effect [Fig. 4d; F(1 190)= 15.96, P <0.0001]. The overall 
genotype effect was most likely caused by the increased 
cocaine-induced locomotor response in saline-pretreated 
SERT rats, while the locomotor responses after S-15535 
were comparable in SERT / and SERT+ + rats. These data 
show that particularly SERT+ + rats increased their respond­
ing to 20 mg/kg dose of cocaine after S-15535 pretreatment. 
In contrast to 8-OHDPAT, S-15535 increased center time at 
20 mg/kg cocaine, in SERT+/+ rats only [F(1,190)=4,50, 
P<0.05; not shown]. At 10 mg/kg cocaine, S-15535 
pretreatment had no significant effect on center time [F 
(11,109) (pretreatment effect)=0.51, n.s.; F(11,109) (geno­
type effect)=0.00, n.s.; not shown].
Pretreatment with 0.3 mg/kg WAY-100635, a dose sug­
gested to inhibit postsynaptic 5-HT1A receptors (Müller et al. 
2007), by itself had no genotype or pretreatment effect 
[Fig. 4e; F (1 ;41)=0, n.s.]. Likewise, 0.05 mg/kg WAY-100635, 
a dose assumed to inhibit presynaptic 5-HT1A receptors 
(Carey et al. 2005), did not affect locomotor activity in 
SERT++ and SERT- -  rats [Fig. 4f; F (1,46)=1.32, n.s.]. After 
the 20-mg/kg cocaine challenge, pretreatment with 0.3 mg/kg 
WAY-100635 induced a significant overall genotype [Fig. 4e; 
F(1134)=6.40, P<0.05] and genotype x pretreatment effect 
[F(11;134)=2.57, P <0.01]. According to Newman-Keuls post 
hoc test, there were no genotype difference when 0.3 mg/kg 
WAY-100635 pretreated SERT++ and SERT- -  rats were 
compared. However, 0.3 mg/kg WAY-100635 pretreatment 
reduced cocaine-induced hyperactivity relative to vehicle 
pretreatment in SERT-/- rats at 10, 20, 30, 40, and 60 min 
after the cocaine injection [P<0.05], while in SERT+/+ rats, 
WAY-100635 pretreatment, compared to vehicle pretreat­
ment, significantly reduced cocaine-induced activity only at 
20 min after the cocaine challenge [P<0.05]. A 0.05-mg/kg 
WAY-100635 pretreatment also induced an overall genotype 
effect [Fig. 4f; F(1 130)=9.78, P<0.005], but no significant 
genotype x pretreatment interaction was found [F(11130)= 
1.15, n.s.]. Center time was significantly enhanced in SERT 
+/+ and SERT-/- rats treated with 0.3 mg/kg WAY100635 
and 20 mg/kg cocaine [F(11,134)= 19.16, P<0.0001; not 
shown], without genotype differences [F(1,134)=0.18, n.s.; 
not shown]. A similar response pattern was observed after 
0.05 mg/kg WAY100635 combined with 20 mg/kg cocaine 
[F(11,130) (pretreatment effect=24.75, P<0.0001; F(1,130) 
(genotype effect)=1.98, n.s.; not shown].
Discussion
SERT- -  rats are supersensitive to cocaine
Here, we show that SERT / rats are supersensitive to 
cocaine as measured in three distinct behavioral procedures, 
namely, cocaine-induced locomotor activity, cocaine-in­
duced CPP, and intravenous cocaine self-administration. 
SERT mice also display enhanced cocaine-induced CPP 
(Sora et al. 1998, 2001, but see Hall et al. 2002), but in 
contrast to the SERT-/- rat, cocaine-induced hyperactivity 
is reduced in SERT-/- mice (Wichems et al. 1998). 
Procedural differences may underlie these contrasting 
findings, but there may also be species differences 
regarding developmental adaptations in response to the 
absence of the SERT or interference with genetic back­
ground that differ between rat and mouse strains. We also 
show that 5-HT1A receptor agonists differentially affect 
cocaine’s psychomotor effects in SERT- -  and SERT+ + rats 
at low and high cocaine doses, implying that a mechanism 
through which cocaine supersensitivity is mediated in 
SERT- -  rats involves, among other 5-HT receptors, the 5- 
HT1A receptor. Together, three important conclusions can 
be drawn from this study: (1) cocaine-induced locomotor 
activity in SERT / rats is predictive for enhanced intrave­
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nous cocaine self-administration, implying common under­
lying mechanisms, (2) 5-HT plays an important modulatory 
role in the mechanisms by which cocaine exerts its 
behavioural effects, and (3] compensatory adaptations in 
5-HT1A receptor function may contribute to the cocaine 
supersensitivity in SERT rats.
Altered 5-HT1A receptor responsivity in SERT rats
We previously observed a profound increase in extracellular 
5-HT levels in SERT- -  rats (Homberg et al. 2007) that 
could potentially affect the functioning of 5-HT receptors, 
as has been reported after chronic SSRI treatment (Blier et
Fig. 4 Effect of 0.25 mg/kg 8-OHDPAT (s.c.) pretreatment on locomotor 
activity in male SERT+/+ and SERT-/- rats induced by a 10 mg/kg (n=5) 
and b 20 mg/kg (n=6) cocaine. Effect of 2.5 mg/kg S-15535 (s.c.) 
pretreatment on locomotor activity in male SERT+/+ and SERT-/- rats 
induced by (c) 10 mg/kg (n=5-6) and (d) 20 mg/kg (n=10-11) cocaine. 
The locomotor response to 20 mg/kg cocaine after e 0.3 mg/kg WAY- 
100635 (n=5) and f 0.05 mg/kg WAY-100635 (n=5) pretreatment. 
Habituation took place at 0-30 min; from 30 to 60 min, the effect of a
vehicle injection (s.c.) was measured; at 60 min after start of the test the 
animals received 8-OHDPAT, S-15535 or WAY100635 pretreatment 
(s.c.); and 20 min later (80 min after start of the test), the animals 
received a 10- or 20-mg/kg cocaine challenge (i.p.). Data represent 
mean (±SEM) distance moved (cm) in 10 min bins. *P<0.05 SERT+/+ 
vs. SERT-/- rats; #P<0.05 SERT+/+ vehicle vs. SERT+/+ pretreatment, 
aP<0.05 SERT-/- vehicle vs. SERT-/- pretreatment
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al. 1990) and in human carrying the s/s genotype of the 5- 
HTTLPR (David et al. 2005). We found that 8-OHDPAT- 
induced hypothermia was decreased in SERT- -  rats and 
that S15535-induced attenuation of SIH as found in SERT+ + 
and SERT+/ rats was converted into a potentiation of the 
SIH in SERT rats. These findings may either be 
explained by constitutive occupation of 5-HT1A receptors 
because of the high endogenous 5-HT tonus or by 
desensitization of the receptors as a compensatory adaptive 
response to the high endogenous 5-HT tonus, or both. 
Autoradiography revealed significant decreases in 5-HT1A 
receptor density in the raphe nuclei and several terminal 
regions, suggesting that 5-HT1A receptors are (slightly) 
desensitized in SERT-/- rats. To a large extent, corresponding 
findings have been obtained in SERT-/- mice (e.g., Li et al. 
1999; Fabre et al. 2000). Nevertheless, it is still possible that 
the reduced 5-HT1A receptor-mediated hypothermic 
responses in SERT-/- rats (partially) reflects occupation of 
(agonist-desensitized) 5-HT1A receptors because of the high 
endogenous 5-HT tonus.
In rats (e.g., Millan et al. 1993b; Bill et al. 1991; 
Goodwin et al. 1987) and humans (Blier et al. 2002), 5- 
HT1A receptor-induced hypothermia is thought to be 
mediated by postsynaptic 5-HT 1A receptors, while in mice, 
the somatodendritic 5-HT1A receptors seem to be involved 
(Goodwin et al. 1985; Martin et al. 1992), although some 
controversies regarding the pre- and postsynaptic modula­
tion of 5-HT1A receptor-mediated hypothermia in rat exist 
(Higgins et al. 1988; Hillegaart 1991). However, combined 
with our observation that 8-OHDPAT-induced activity and 
5-HT syndrome, which are postsynaptically mediated 
(Yamada et al. 1988), were reduced in SERT rats relative 
to SERT+ + rats in the locomotor tests, the 8-OHDPAT- 
induced hypothermia findings imply that predominantly 
postsynaptic 5-HT1A receptors are involved. This view is 
further supported by the lack of a hypothermic effect of S- 
15535 (Millan et al. 1993a; de Boer et al. 2000). Previous 
studies have convincingly demonstrated that this compound 
is a full somatodendritic 5-HT1A receptor agonist and has 
only weak partial agonistic or even antagonistic properties 
at postsynaptic 5-HT1A receptor (Millan et al. 1993a; 
Newman-Tancredi et al. 1999; de Boer et al. 2000).
Regarding the SIH, it is not clear whether this short- 
lasting thermogenic effect is mediated by somatodendritic 
or postsynaptic 5-HT1A receptors, or both. The fact that S- 
15535 dose-dependently attenuated SIH in SERT+/+ and 
SERT+/- rats indicates involvement of somatodendritic 
sites. Strikingly, S-15535 enhanced rather than reduced 
SIH in SERT / rats. Considering the high 5-HT tonus in 
SERT / rats, and thus increased occupation of 5-HT1A 
receptors, this most probably reflects the antagonistic 
properties of S-15535 at (agonist-desensitized) postsynaptic 
5-HT1A receptors. In support, WAY-100635, the prototyp­
ical and selective 5-HT1A receptor antagonist, similarly 
enhances SIH in SERT / rats only (unpublished observa­
tions, J.O. and S.d.B.). In the SERT- -  rats, this antagonistic 
effect may have masked the somatodendritic effects of S- 
15535, and therefore, the S15535-SIH data do not allow us 
to conclude as to whether the function of somatodendritic 5- 
HT1A receptors has been changed. The pharmacological 
profile of S-15535, combined with the reduced 5-HT1A 
receptor binding in the raphe nuclei of SERT-/- rats, and the 
finding that somatodendritic 5-HT1A receptors are strongly 
desensitized in SERT- -  mice (Gobbi et al. 2001), show that 
the S-15535-SIH data may point to desensitized somatoden­
dritic 5-HT1A receptors in SERT / rats.
Altered 5-HT 1A receptor responsivity contributes to cocaine 
supersensitivity
The effect of cocaine on extracellular monoamine levels is 
dependent upon the activity of the monoamine transporters. 
Because the presynaptic functioning of non-serotonergic 
neurons is not affected in the SERT-/- rat, at least under 
basal conditions (Homberg et al. 2007), and a differential 
monoamine response to a cocaine challenge is only seen for 
5-HT in SERT- -  mice and rats (Shen et al. 2004; J.H., E.C., 
J.O., unpublished observations), our results imply that the 
observed cocaine supersensitivity is not exerted by noradren­
ergic and dopaminergic systems, but results from a primary 
effect of the disturbed serotonergic system. However, in view 
of the complex interactions between central 5-HT, DA and 
NA systems, we cannot exclude that alterations in mesolimbic 
dopaminergic or noradrenergic receptor density or sensitivity 
contribute to the behavioral changes in SERT rats.
The current idea concerning the role of 5-HT in the 
behavioural effects of cocaine involves an inhibitory role of 
5-HT. Thus, increasing 5-HT levels generally inhibits 
cocaine self-administration (Carroll et al. 1990; Richardson 
and Roberts 1991; Peltier and Schenk 1993; but see Porrino 
et al. 1989; Tella 1995). Because cocaine-induced 5-HT 
release is reduced in SERT- -  mice and rats (Shen et al. 
2004; J.H., E.C., J.O., unpublished observations), because 
both SERT-/- mice and rats show increased cocaine- 
induced CPP (Sora et al. 1998, 2001; present study), and 
because novelty-induced locomotor activity was compara­
ble in SERT+ + and SERT- -  rats, cocaine supersensitivity 
in SERT-/- models may be explained by reduced 5-HT 
dampening of the cocaine’s effects. The mechanism 
underlying this 5-HT dampening is not understood. As 
activation of inhibitory somatodendritic 5-HT1A receptors 
reduces the firing rate of raphe neurons and subsequently 5- 
HT and DA release in terminal regions (Yoshimoto and 
McBride 1992; Herges and Taylor 1999; Andrews et al. 
2005), desensitization of somatodendritic 5-HT1A receptors 
in SERT- -  models may mediate the reduced 5-HT
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dampening and cocaine supersensitivity. On the other hand, 
there are also indications that somatodendritic 5-HT1A 
receptors facilitate psychostimulant addiction-related 
behaviors and that postsynaptic 5-HT1A receptors predom­
inantly inhibit psychostimulant-induced locomotor activity 
(Müller et al. 2007). In this respect, desensitization of 
postsynaptic 5-HT1A receptors in SERT models may 
potentiate cocaine’s psychomotor effects, and desensitiza­
tion of somatodendritic 5-HT1A receptors may exert an 
inhibitory effect. To extend the thermal findings and to 
study whether and how 5-HT1A receptors contribute to 
SERT-/--induced cocaine supersensitivity, we tested the 
effects of 5-HT1A receptor ligands on cocaine’s psychomo­
tor effects. Cocaine-induced hyperactivity was chosen as 
behavioural indicator because it may have predictive value 
for intravenous cocaine self-administration in SERT rats 
and may be more readily to interpret. Both S-15535 and 8- 
OHDPAT were found to enhance cocaine’s psychomotor 
effects in SERT+ + and SERT- -  rats. While the effects of
0.25 mg/kg 8-OHDPAT are most likely to be mediated by 
postsynaptic receptors, as reported by others (Müller et al. 
2007), the effects of S-15535 may be more difficult to 
interpret because of its pharmacological profile (Millan et al. 
1993a; Newman-Tancredi et al. 1999; de Boer et al. 2000). 
In contrast to 8-OHDPAT, S-15535 by itself had no effect 
on activity, which suggests at least that S-15535 did not act 
as postsynaptic 5-HT1A receptor agonist. A postsynaptic 
antagonistic effect is also not likely, as both S-15535 and 8- 
OHDPAT enhanced cocaine’s psychomotor effects. Activa­
tion of somatodendritic 5-HT1A receptors is known to be 
associated with a reduction in spontaneous activity (Müller 
et al. 2007), and thus the most likely explanation is that the 
failure of S-15535 to affect locomotor activity in habituated 
animals reflects a somatodendritic agonistic effect. If this 
assumption is correct, our data show that activation of both 
somatodendritic and postsynaptic 5-HT1A receptors facilitate 
cocaine’s effects in SERT- -  rats. Furthermore, because 
SERT-/- rats were highly responsive to 8-OHDPAT and S- 
15535, despite their high endogenous 5-HT tonus, it is most 
likely that desensitization of postsynaptic and somatodendritic 
5-HT1A receptors in the SERT rat facilitates the effects of 
low doses of cocaine, rather than receptor occupation.
At a high cocaine dose (20 mg/kg), 8-OHDPAT and S- 
15535 pretreatment had no further effects in SERT-/- rats, 
possibly because somatodendritic and postsynaptic 5-HT1A 
receptors in SERT- -  were maximally activated. The 
selective 5-HT1A receptor antagonist WAY-100635, at 
doses inhibiting either somatodendritic (0.05 mg/kg) or 
postsynaptic 5-HT1A receptors (0.3 mg/kg), reduces co­
caine-induced hyperactivity in SERT / , but not SERT+ + 
rats, which supports this suggestion. Thus, there could have 
been more competition between 5-HT and WAY-100635 to 
bind to the 5-HT1A receptor in SERT- -  rats. As cocaine
more effectively induced 5-HT release in SERT+/+ mice/rats 
compared to SERT- -  mice (Shen et al. 2004) and rats (J.H., 
E.C., J.O., unpublished observations), receptor occupation 
by endogenous 5-HT does not seem to explain these 
findings. It is more likely that the reduced responsiveness 
to 8-OHDPAT and S-15535 at high cocaine doses is also 
due to 5-HT1A receptor desensitization. Hence, the remark­
able finding is that 5-HT1A receptor desensitization facili­
tates low-dose cocaine effects, while attenuating high dose 
cocaine effects. This implies that genotype differences 
between SERT- -  and SERT+ + rats in cocaine sensitivity 
will mainly be found at low cocaine doses, as was seen 
during FR1 responding in the self-administration proce­
dure. Yet, in the present study, cocaine doses may not have 
been high enough to diminish genotype differences in the 
locomotor and CPP tests.
The effects of 8-OHDPAT and S-15535 differed in that 
8-OHDPAT combined with 20 mg/kg cocaine affected the 
intensity of the locomotor response in SERT+ + rats, while
S-15535 combined with the same dose of cocaine reduced 
the response latency and increased the duration of the 
locomotor response in these animals. These findings argue 
against the possibility that reduced cocaine-induced loco­
motor activity in SERT+/+ rats after saline pretreatment 
reflected stereotypy. Although speculative, it might be that 
the response intensity is mediated by 5-HT1A receptors in 
mesolimbic structures that are known to play a central role 
in reward (Koob 1992) and that somatodendritic 5-HT1A 
receptors affect the duration of the response by their control 
over raphe firing rate and thus 5-HT release and synthesis 
throughout the brain. Our data suggest that the latter 
mechanism is sated earlier than the postsynaptic mechanism 
regarding cocaine-induced locomotor activity.
An increase in center time in an open field test is 
generally interpreted as an anxiolytic effect. Because center 
time did not differ between saline-pretreated SERT+/+ and 
SERT- -  rats, it is not likely that genotype differences in 
sensitivity to cocaine’s anxiolytic effects explain the 
increased sensitivity to cocaine-induced locomotor activity 
in SERT-/- rats. Strikingly, while 8-OHDPAT combined 
with 20 mg/kg cocaine reduced center time, S-15535 
increased center time, in SERT+/+ rats only. Consistent 
with the present observation, De la Garza and Cunningham 
(2000) reported that 0.2 mg/kg 8-OHDPAT increased 
peripheral locomotor activity, while it reduced activity in 
the center of the open field. The increase in center time 
after S-15535 pretreatment implies that, while 8-OHDPAT 
mediates an anxiogenic effect combined with cocaine, S- 
15535 has an anxiolytic effect. Because both 8-OHDPAT 
and S-15535 have anxiolytic effects in classical tests of 
anxiety (Dekeyne et al. 2000) and because center time does 
not seem to be proportional to the horizontal locomotor 
response, anxiety cannot explain the present observations.
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8-OHDPAT decreases (Müller et al. 2003) and WAY- 
100635 increases (Müller et al. 2002) cocaine-induced 5-HT 
release in the nucleus accumbens. Furthermore, S-15535 
suppresses dialysate levels of 5-HT in the hippocampus 
(Dekeyne et al. 2000). It is therefore tempting to speculate 
that S-15535 and 8-OHDPAT increased cocaine’s psycho­
motor effects by shifting the 5-HT-DA balance to the more 
dopaminergic side when 5-HT levels decrease (Carey et al. 
2004, 2005). In SERT- -  models, relatively reduced cocaine- 
induced 5-HT release (Shen et al. 2004) could thus result in a 
more dopaminergic type of response to cocaine. Because 
cocaine-induced dopamine, and also noradrenaline, release is 
not changed in the prefrontal cortex, caudate putamen, 
nucleus accumbens, and hippocampus of SERT- -  models 
(Shen et al. 2004; J.H., E.C., J.O., unpublished observa­
tions), such a serotonin to dopamine shift should be an 
indirect one. It could be that indirect pathways via 
desensitized 5-HT1A receptors are involved in SERT- -  rats. 
In addition, other 5-HT receptors may contribute to such 
indirect pathways, as we found that the 5-HT1B receptor 
agonist CP94,253 also influenced cocaine-induced locomo­
tor activity differentially in SERT / and SERT++ rats, 
respectively (J.H. unpublished observations). Identification 
of compensatory mechanisms affecting cocaine supersensi­
tivity in SERT-/- rats may ultimately contribute to the 
development of more effective treatments for cocaine 
vulnerable subjects.
Interestingly, in the cocaine self-administration procedure, 
responding was enhanced during the FR1 schedule (acquisi­
tion), when a low dose of cocaine was available, and during 
the PR schedule, when a high dose of cocaine was available. 
Thus, the genotype effect was schedule dependent, in such a 
way that an effect was only seen when the cocaine/response 
ratio was low. This suggests that SERT- -  rats were prepared 
to work harder to obtain reward and that it is not likely that 
increased responding is because stereotypy. Similarly, fluox­
etine and 8-OHDPAT only decreased cocaine self-adminis­
tration when responding was high (Peltier and Schenk 1993), 
implying that the desensitized postsynaptic 5-HT1A receptors 
in SERT rats are involved in “cost-to-benefit” scaling. 
Furthermore, during the PR schedule, but not the FR1 
schedule, the number of inactive responses was significantly 
increased in SERT rats. Hence, the increased PR 
responding in these animals may relate to insensitivity to 
extinction. During extinction, responding was increased in 
SERT+ + compared to SERT+- and SERT- -  rats across 
sessions 1-5, but during subsequent sessions, SERT-/- rats 
failed to extinguish responding towards the previously 
rewarded nose poke hole. The reduced cocaine/response 
ratio in SERT / , at least during the PR schedule, might 
therefore reflect perseveration. The finding that central 5-HT 
depletion (Tran-Nguyen et al. 2001) reduces extinction 
responding in cocaine-trained animals is in line with the
present observation. Paradoxically, chronic fluoxetine treat­
ment in cocaine-trained adult rats reduces extinction 
responding (Baker et al. 2001), while prenatal chronic 
fluoxetine exposure increases extinction responding and, in 
addition, increases cocaine-induced conditioned place prefer­
ence (Forcelli and Heinrichs 2008). Considering 5-HT as a 
potent neurotropic factor (Lauder 1990), early excess 5-HT, 
induced by prenatal fluoxetine or genetic inactivation of the 
serotonin transporter, may cause persistent neuroadaptations. 
Although highly speculative, these neuroadaptations may 
involve those found in relation to the 5-HTTLPR; a 
functional uncoupling between the anterior cingulated cortex 
and amygdala is hypothesized to be associated with 
emotional perseveration (Pezawas et al. 2005).
Conclusion
Taken together, we show that SERT-/- rats are supersensitive 
to cocaine in three behavioural tests measuring distinct aspects 
of cocaine’s effects. Importantly, this behavioral phenotype is 
not only attributable to the absence of the SERT, but is also 
influenced by desensitization of 5-HT1A receptors and 
possibly by functional changes in other 5-HT receptors. Our 
data not only highlight the role of 5-HT1A receptors in 
cocaine vulnerability, but also stress the importance of 
addressing compensatory adaptations in SERT-/- and other 
knockout models, as they are relevant to constitutive trait-like 
individual differences in central 5-HT levels which may 
require individualized pharmacotherapy. For these reasons, 
future studies should extent our findings to the intravenous 
drug self-administration procedure.
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